Patents by Inventor Scott L. Tarriff

Scott L. Tarriff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration
    Patent number: 9579384
    Abstract: Methods of treating bendamustine responsive conditions in patients having fluid and/or sodium intake restrictions are disclosed. The methods include identifying patients having such restrictions and in need of bendamustine, and then administering thereto a bendamustine-containing composition in a volume of about 120 ml or less intravenously over a period of about 15 minutes or less. The smaller volumes and reduced sodium load as compared to currently known methods of treatment minimize cardiac and/or renal stress in patients having diseases such as congestive heart failure or renal disease.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: February 28, 2017
    Assignee: EAGLE PHARMACEUTICALS, INC.
    Inventors: Srikanth Sundaram, Scott L. Tarriff
  • METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION
    Publication number: 20150343061
    Abstract: Methods of treating bendamustine responsive conditions in patients having fluid and/or sodium intake restrictions are disclosed. The methods include identifying patients having such restrictions and in need of bendamustine, and then administering thereto a bendamustine-containing composition in a volume of about 120 ml or less intravenously over a period of about 15 minutes or less. The smaller volumes and reduced sodium load as compared to currently known methods of treatment minimize cardiac and/or renal stress in patients having diseases such as congestive heart failure or renal disease.
    Type: Application
    Filed: August 6, 2015
    Publication date: December 3, 2015
    Inventors: Srikanth SUNDARAM, Scott L. Tarriff
  • Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration
    Patent number: 9000021
    Abstract: Methods of treating bendamustine responsive conditions in patients having fluid and/or sodium intake restrictions are disclosed. The methods include identifying patients having such restrictions and in need of bendamustine, and then administering thereto a bendamustine-containing composition in a volume of about 120 ml or less intravenously over a period of about 15 minutes or less. The smaller volumes and reduced sodium load as compared to currently known methods of treatment minimize cardiac and/or renal stress in patients having diseases such as congestive heart failure or renal disease.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: April 7, 2015
    Assignee: Eagle Pharmaceuticals, Inc.
    Inventors: Srikanth Sundaram, Scott L. Tarriff
  • METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION
    Publication number: 20150080444
    Abstract: Methods of treating bendamustine responsive conditions in patients having fluid and/or sodium intake restrictions are disclosed. The methods include identifying patients having such restrictions and in need of bendamustine, and then administering thereto a bendamustine-containing composition in a volume of about 100 ml or less intravenously over a period of about 30 minutes or less. The smaller volumes and reduced sodium load as compared to currently known methods of treatment minimize cardiac and/or renal stress in patients having diseases such as congestive heart failure or renal disease.
    Type: Application
    Filed: November 26, 2014
    Publication date: March 19, 2015
    Inventors: Srikanth Sundaram, Scott L. Tarriff
  • METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION
    Publication number: 20130253026
    Abstract: Methods of treating bendamustine responsive conditions in patients having fluid and/or sodium intake restrictions are disclosed. The methods include identifying patients having such restrictions and in need of bendamustine, and then administering thereto a bendamustine-containing composition in a volume of about 120 ml or less intravenously over a period of about 15 minutes or less. The smaller volumes and reduced sodium load as compared to currently known methods of treatment minimize cardiac and/or renal stress in patients having diseases such as congestive heart failure or renal disease.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 26, 2013
    Applicant: EAGLE PHARMACEUTICALS, INC.
    Inventors: Srikanth Sundaram, Scott L. Tarriff
  • Vial with collar label
    Patent number: D676572
    Type: Grant
    Filed: October 3, 2011
    Date of Patent: February 19, 2013
    Assignee: Eagle Pharmaceuticals, Inc.
    Inventor: Scott L. Tarriff